Trusted Resources: Education
Scientific literature and patient education texts
Gastrointestinal Manifestations in Mucopolysaccharidosis Type III: Review of Death Certificates and the Literature
source: Journal of clinical medicine
year: 2021
authors: Thomas S,Ramaswami U,Cleary M,Yaqub M,Raebel EM
summary/abstract:Mucopolysaccharidosis type III (MPS III, Sanfilippo disease) is a life-limiting recessive lysosomal storage disorder caused by a deficiency in the enzymes involved in degrading glycosaminoglycan heparan sulfate. MPS III is characterized by progressive deterioration of the central nervous system. Respiratory tract infections have been reported as frequent and as the most common cause of death, but gastrointestinal (GI) manifestations have not been acknowledged as a cause of concern. The aim of this study was to determine the incidence of GI problems as a primary cause of death and to review GI symptoms reported in published studies.
organization: The Society for Mucopolysaccharide and Related Diseases, MPS House, Amersham HP7 9LP, UK.DOI: 10.3390/jcm10194445
read more
Related Content
-
Cure Sanfilippo Foundation – FacebookCure Sanfilippo Foundation is 501c3 nonp...
-
Wendy FergusonWendy Ferguson is the President and Secr...
-
Sleep-Related Hypermotor Epilepsy in a Patient With Mucopolysaccharidosis Type IIIBoth non-epileptic sleep disturbances an...
-
Intracerebral Gene Therapy in Four Children With Sanfilippo B Syndrome: 5.5-Year Follow-Up ResultsWe report the safety (primary endpoint) ...
-
Understanding How Enzymes Work and Affect Our Bodyhttps://slideplayer.com/slide/7566393/...
-
Sanfilippo Syndrome (MPS III)https://www.onempsvoice.com/wp-content/u...
-
Believe in G Golf TournamentGianna, was diagnosed with Sanfilippo Sy...